The Role of Human HtrA1 in Arthritic Disease*

Human HtrA1 belongs to a widely conserved family of serine proteases involved in various aspects of protein quality control and cell fate. Although HtrA1 has been implicated in the pathology of several diseases, its precise biological functions remain to be established. Through identification of potential HtrA1 targets, studies presented herein propose that within the context of arthritis pathology HtrA1 contributes to cartilage degradation. Elevated synovial HtrA1 levels were detected in fluids obtained from rheumatoid and osteoarthritis patients, with synovial fibroblasts identified as a major source of secreted HtrA1. Mass spectrometry analysis of potential HtrA1 substrates within synovial fluids identified fibronectin as a candidate target, and treatment of fibronectin with recombinant HtrA1 led to the generation of fibronectin-degradation products that may be involved in cartilage catabolism. Consistently, treatment of synovial fibroblasts with HtrA1 or HtrA1-generated fibronectin fragments resulted in the specific induction of matrix metalloprotease 1 and matrix metalloprotease 3 expression, suggesting that HtrA1 contributes to the destruction of extracellular matrix through both direct and indirect mechanisms.

[1]  David I. Smith,et al.  Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. , 2002, Cancer research.

[2]  R. Toes,et al.  Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10 , 2002, Annals of the rheumatic diseases.

[3]  David I. Smith,et al.  A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer , 2004, Oncogene.

[4]  T. Glant,et al.  Appearance and persistence of fibronectin in cartilage , 2004, Histochemistry.

[5]  R. Colman,et al.  Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation. , 1988, The Journal of clinical investigation.

[6]  D. Luk,et al.  Human HtrA, an Evolutionarily Conserved Serine Protease Identified as a Differentially Expressed Gene Product in Osteoarthritic Cartilage* , 1998, The Journal of Biological Chemistry.

[7]  Masato Yano,et al.  Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. , 2004, The Biochemical journal.

[8]  M. Ehrmann,et al.  Characterization of presenilin-amyloid precursor interaction using bacterial expression and two-hybrid systems for human membrane proteins , 2004, Molecular membrane biology.

[9]  U. Müller-Ladner,et al.  MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction? , 2002, Annals of the rheumatic diseases.

[10]  N. Bhardwaj,et al.  Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. , 1992, Arthritis and rheumatism.

[11]  C. Southan,et al.  The HtrA family of proteases: implications for protein composition and cell fate. , 2002, Molecular cell.

[12]  S. Krane,et al.  Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Griffiths,et al.  Fragmented fibronectin and other synovial fluid proteins in chronic arthritis: their relation to immune complexes. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[14]  B. Caterson,et al.  Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan. , 1983, The Journal of biological chemistry.

[15]  P. Richards,et al.  Pro-inflammatory effects of the aminobisphosphonate ibandronate in vitro and in vivo. , 1999, Rheumatology.

[16]  J. Zumbrunn,et al.  Primary structure of a putative serine protease specific for IGF‐binding proteins , 1996, FEBS letters.

[17]  L. Salamonsen,et al.  Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterization of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2. , 2003, The Biochemical journal.

[18]  G. Ossenkoppele,et al.  Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study. , 1991, Journal of immunological methods.

[19]  D. Xie,et al.  Fibronectin fragments alter matrix protein synthesis in cartilage tissue cultured in vitro. , 1993, Archives of biochemistry and biophysics.

[20]  W. English,et al.  Matrix metalloproteinases in arthritic disease , 2002, Arthritis research.

[21]  D. Hocking,et al.  Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. , 2002, Molecular biology of the cell.

[22]  J. MacLeod,et al.  Cartilage fibronectin isoforms: in search of functions for a special population of matrix glycoproteins. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[23]  Smith Rl.  Degradative enzymes in osteoarthritis. , 1999 .

[24]  Y. Okada,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis , 2000, Annals of the rheumatic diseases.

[25]  A. Cole,et al.  A single injection of fibronectin fragments into rabbit knee joints enhances catabolism in the articular cartilage followed by reparative responses but also induces systemic effects in the non-injected knee joints. , 2001, Osteoarthritis and cartilage.

[26]  V. Bennett,et al.  The splicing pattern of fibronectin mRNA changes during chondrogenesis resulting in an unusual form of the mRNA in cartilage. , 1991, The Journal of biological chemistry.

[27]  D. Noonan,et al.  The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells , 2002, Oncogene.

[28]  M. Kawaichi,et al.  Developmentally regulated expression of mouse HtrA3 and its role as an inhibitor of TGF‐β signaling , 2004, Development, growth & differentiation.

[29]  L. Lohmander,et al.  Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. , 1993, Arthritis and rheumatism.

[30]  Thomas Aigner,et al.  Articular cartilage and changes in Arthritis: Cell biology of osteoarthritis , 2001, Arthritis Research & Therapy.

[31]  I. Clemmensen,et al.  Demonstration of fibronectin in human articular cartilage by an indirect immunoperoxidase technique , 2004, Histochemistry.

[32]  J. Mort,et al.  Articular cartilage and changes in arthritis: Matrix degradation , 2001, Arthritis research.

[33]  R. Dobrowsky,et al.  Decreased activity and enhanced nuclear export of CCAAT-enhancer-binding protein beta during inhibition of adipogenesis by ceramide. , 2002, The Biochemical journal.

[34]  P. Roughley.  Articular cartilage and changes in arthritis: Noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage , 2001, Arthritis research.

[35]  G. Lust,et al.  Fibronectin in osteoarthritic canine articular cartilage. , 1982, Biochemical and biophysical research communications.

[36]  M. Kawaichi,et al.  Expression of mouse HtrA1 serine protease in normal bone and cartilage and its upregulation in joint cartilage damaged by experimental arthritis. , 2005, Bone.

[37]  C. Brinckerhoff,et al.  Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors , 2001, Arthritis Research & Therapy.

[38]  G. Homandberg,et al.  Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. , 1992, The Journal of biological chemistry.

[39]  Eric P Hoffman,et al.  A web-accessible complete transcriptome of normal human and DMD muscle , 2002, Neuromuscular Disorders.

[40]  A. Nagano,et al.  Levels of Rheumatoid Factor Isotypes, Metalloproteinase-3 and Tissue Inhibitor of Metalloproteinase-1 in Synovial Fluid from Various Arthritides , 2000, Clinical Rheumatology.